BioMedX Group, Inc. | About BioMedX Group
page-template,page-template-full_width,page-template-full_width-php,page,page-id-13396,qode-quick-links-1.0,woocommerce-no-js,ajax_fade,page_not_loaded,,columns-4,qode-theme-ver-11.0,qode-theme-bridge,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

About BioMedX Group

BioMedX Group, Inc. is a medical technology company transforming the cosmetic surgery consultation experience by delivering accurate and realistic simulation results through its proprietary 3D Physics Engine that factors in bone structure, muscle-tissue connectivity and skin elasticity to predict the results of the cosmetic procedure in real-time. The Company’s integrated solution of hardware and software is further enhanced by Artificial Intelligence to empower doctors and patients to make better informed decisions and minimize surgical risks.

Latest News

  • Focus on ChromaID to Aid in Enhanced 3-D and Holographic Imaging for Certain Medical Procedures SEATTLE–(BUSINESS WIRE)–Dec. 7, 2016– Visualant, Inc. (OTCQB: VSUL) – a photonics technology development company providing chromatic-based identification,



Rudy A. Mazzocchi

Co-Founder & CEO

  • 30+ Years of Executive Management experience in the Med-tech and Biotechnology Industry
  • Entrepreneur of the Year in 2004 and 2013
  • Experiences in Image-guided Surgery with over 50 Patents filed in the Medical Device Industry
  • Former Partner in Venture Capital Funds
  • Director of both Public and Private Venture-backed Companies


Raghu Raghavan, PhD.

Chief Technology Officer

  • 30+ Years of Computational & Computer Science Experience
  • Former Professor of Computer Science & Radiology at Johns Hopkins University (Baltimore, MD)
  • Author of the Brain Atlas and Developer of the 3D-Interactive Haptics, VR-Simulation Planning Platforms in Reconstructive Surgery and Neurosurgery, and Interactive Virtual Surgical Tools
  • Author of over 150 Research Publication & 37 Patents